Disarm Therapeutics, Inc., based in Cambridge, MA, is a biotechnology company focused on developing innovative therapeutics for neurodegenerative diseases. The company specializes in harnessing advanced scientific research to create treatments that target the underlying mechanisms of these conditions. By leveraging expertise in molecular biology and pharmacology, Disarm aims to address significant unmet medical needs in the field of neurology, contributing to improved patient outcomes and quality of life.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

10 Patents

#231 in Cambridge, MA

#1,773 in Massachusetts

#29,882 in US

#56,092 in the World

Cambridge, MA, United States of America

Disarm Therapeutics, Inc.

Forward Citations = 1

21 inventors:

Robert Owen Hughes (10 out of 26 patents)

Rajesh Devraj (10 out of 32 patents)

Todd Bosanac (8 out of 30 patents)

4. Andrew Simon Brearley (6 out of 7 patents)

5. Jonathan Bentley (5 out of 13 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Disarm Therapeutics, Inc.. Retrieved from https://idiyas.com/company/disarm-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

5 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]